The U.S. Food and Drug Administration has now approved Botox injections to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month. “Chronic migraine is one of the most disabling forms of headache,” said Russell Katz, M.D., director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research. “Patients with chronic migraine experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective treatment options available.”
Migraine headaches are described as an intense pulsing or throbbing pain in one area of the head. The headaches are often accompanied by nausea, vomiting, and sensitivity to light and sound. Migraine is three time more common in women than in men. Migraine usually begins with intermittent headache attacks 14 days or fewer each month (episodic migraine), but some patients go on to develop the more disabling chronic migraine.
To treat chronic migraines, Botox is given approximately every 12 weeks as multiple injections around the head and neck to try to dull future headache symptoms. Dr. Rouzati specializes in the use of Botox injections for the treatment of chronic migraines and takes great pride in being able to reduce the pain and suffering his patients experience as a result of this condition. To book a complimentary consultation with Dr. Rouzati to discuss your migraine condition and effective treatments to reduce their frequency, please contact our clinic directly and our staff will be happy to make an appointment for you.